BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1825535)

  • 1. Mechanism-based inactivation of thromboxane A2 synthase.
    Fitzpatrick FA; Jones D; Winitz S; Fish HT
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21A():161-3. PubMed ID: 1825535
    [No Abstract]   [Full Text] [Related]  

  • 2. A concept for the mechanism of prostacyclin and thromboxane A2 biosynthesis.
    Ullrich V; Hecker M
    Adv Prostaglandin Thromboxane Leukot Res; 1990; 20():95-101. PubMed ID: 2144703
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostaglandin H2 in human platelet activation: coactivator and substitute for thromboxane A2.
    Hornberger WB; Patscheke H
    Prog Clin Biol Res; 1989; 301():315-9. PubMed ID: 2798452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of platelet thromboxane A2 inactivates purified human platelet thromboxane synthase.
    Hall ER; Tuan WM; Venton DL
    Biochem J; 1986 Feb; 233(3):637-41. PubMed ID: 3707514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostaglandin endoperoxide metabolism by microsomes of whole kidneys from normal, congenital unilateral hydronephrotic and unilateral ureteral obstructed rats.
    McNamara DB; Boineau FG; McMullen-Laird M; Lippton HL; She HS; Lewy JE; Kadowitz PJ
    Prostaglandins; 1982 Nov; 24(5):585-605. PubMed ID: 6962465
    [No Abstract]   [Full Text] [Related]  

  • 6. [Kinetic mechanisms of enzyme activity of the thromboxane synthetase system. Thromboxane synthetase of human platelets].
    Basevich VV; Mevkh AT; Varfolomeev SD
    Biokhimiia; 1984 Sep; 49(9):1538-45. PubMed ID: 6440597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thromboxane synthase catalyses hydroxylations of prostaglandin H2 analogs in the presence of iodosylbenzene.
    Hecker M; Baader WJ; Weber P; Ullrich V
    Eur J Biochem; 1987 Dec; 169(3):563-9. PubMed ID: 3691505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some new prospects in the mechanism of control of arachidonate metabolism in human placenta and amnion.
    Dembélé-Duchesne MJ; Thaler-Dao H; Chavis C; de Paulet AC
    Prostaglandins; 1981 Dec; 22(6):979-1002. PubMed ID: 6801732
    [No Abstract]   [Full Text] [Related]  

  • 9. "Suicide" inactivation of thromboxane A2 synthase. Characteristics of mechanism-based inactivation with isolated enzyme and intact platelets.
    Jones DA; Fitzpatrick FA
    J Biol Chem; 1990 Nov; 265(33):20166-71. PubMed ID: 2243085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prostaglandin synthetase components (author's transl)].
    Robak J; Kasperczyk H
    Postepy Biochem; 1979; 25(4):547-63. PubMed ID: 120943
    [No Abstract]   [Full Text] [Related]  

  • 11. Indirect actions of thapsigargin on human platelets: activation of eicosanoid biosynthesis and cellular signaling pathways.
    Malcolm KC; Fitzpatrick FA
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1244-9. PubMed ID: 1532033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of thromboxane synthase from human platelets as a cytochrome P-450 enzyme.
    Haurand M; Ullrich V
    J Biol Chem; 1985 Dec; 260(28):15059-67. PubMed ID: 2999104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polyvalent TXA2/PGH2 receptor antagonists with very high affinity.
    Zehender H; Patscheke H
    Prog Clin Biol Res; 1989; 301():561-5. PubMed ID: 2529555
    [No Abstract]   [Full Text] [Related]  

  • 14. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
    Jin YR; Cho MR; Lee KS; Lee JJ; Lim Y; Han XH; Oh KW; Hong JT; Yoo HS; Yun YP
    Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):162-7. PubMed ID: 16128910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Macrophages isolated from liver granulomas of murine Schistosoma mansoni synthesize predominantly TxA2 during the acute and chronic phases of infection.
    Tripp CS; Needleman P; Kassab JT; Weinstock JV
    J Immunol; 1988 May; 140(9):3140-3. PubMed ID: 3129511
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biosynthesis and pharmacological modulation of thromboxane in humans.
    Patrono C
    Circulation; 1990 Jan; 81(1 Suppl):I12-5; discussion I22-3. PubMed ID: 2136814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thromboxane synthase inhibitors suppress more effectively the aggregation of thromboxane receptor-desensitized than that of normal platelets: role of adenylylcyclase up-regulation.
    Vezza R; Nenci GG; Gresele P
    J Pharmacol Exp Ther; 1995 Dec; 275(3):1497-505. PubMed ID: 8531121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low density lipoprotein (LDL) from male volunteers stimulated the thromboxane formation by human platelets.
    Beitz J; Panse M; Förster W
    Prostaglandins Leukot Med; 1983 Apr; 10(4):443-8. PubMed ID: 6574527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate inactivation of lung thromboxane synthase preferentially decreases thromboxane A2 production.
    Hall ER; Townsend GL; Linthicum DS; Frasier-Scott KF
    Prostaglandins Leukot Essent Fatty Acids; 1991 Jan; 42(1):31-7. PubMed ID: 2011609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thromboxane formation from arachidonic acid and prostaglandin H2 in rabbit spleen.
    Hidaka T; Ueta T; Ogura R
    J Biochem; 1983 Feb; 93(2):367-73. PubMed ID: 6404897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.